Home › SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research
 

Keywords :   


SRI International Announces PDCellX Xenograft Tumor Model Services To Accelerate Cancer Drug Research

2014-04-30 07:22:26| drugdiscoveryonline News Articles

SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics

Tags: services international research model

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11 EVA 6
23.11 8
23.11SEVENTEEN ALWAYS YOURS Weverse 13
23.11 DX
23.11 No.23/1998
23.11 DVD 9
23.11
23.11 CD His Melody
More »